1987
DOI: 10.1095/biolreprod36.4.949
|View full text |Cite
|
Sign up to set email alerts
|

Transient Shortening of Estrous Cycles in Aging C57BL/6J Mice: Effects of Spontaneous Pseudopregnancy, Progesterone, L-dihydroxyphenylalanine, and Hydergine1

Abstract: Regular estrous cycles can be reinitiated in old acyclic female rats by pharmacologic, hormonal, and environmental manipulations. The most responsive acyclic states are persistent vaginal cornification (PVC) and spontaneous pseudopregnancy (SP). However, it is not known if the irregular cyclicity that precedes acyclicity during aging can also be alleviated. We found that transient shortening of estrous cycles follows smear sequences indicative of pseudopregnancy in C57BL/6J mice, aged 9-15 mo, suggesting a rol… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0

Year Published

1987
1987
2022
2022

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(4 citation statements)
references
References 47 publications
0
4
0
Order By: Relevance
“…For example, a loss of the LH surge, which is necessary to maintain cycles, has been attributed to a loss in hypothalamic catecholaminergic (norepinephrine and dopamine) function with age (Wise, 1984; Mohankumar et al, 1995). If the female rodent is treated with catecholaminergic agonists such as l ‐tyrosine (e.g., rat; Watkins et al, 1975; Cooper and Walker, 1979; Forman et al, 1980) or L ‐dopa (e.g., rat; Quadri et al, 1973; or mouse; Cotzias et al, 1977; Flurkey et al, 1987), the ovulatory surge of LH and ovarian cycles are maintained and reproductive senescence is delayed. In these studies, the effects of catecholamine treatment on LH secretion and subsequent ovarian function were the primary focus.…”
Section: Reproductive Aging and Mammary Tumorsmentioning
confidence: 99%
“…For example, a loss of the LH surge, which is necessary to maintain cycles, has been attributed to a loss in hypothalamic catecholaminergic (norepinephrine and dopamine) function with age (Wise, 1984; Mohankumar et al, 1995). If the female rodent is treated with catecholaminergic agonists such as l ‐tyrosine (e.g., rat; Watkins et al, 1975; Cooper and Walker, 1979; Forman et al, 1980) or L ‐dopa (e.g., rat; Quadri et al, 1973; or mouse; Cotzias et al, 1977; Flurkey et al, 1987), the ovulatory surge of LH and ovarian cycles are maintained and reproductive senescence is delayed. In these studies, the effects of catecholamine treatment on LH secretion and subsequent ovarian function were the primary focus.…”
Section: Reproductive Aging and Mammary Tumorsmentioning
confidence: 99%
“…2). P antagonized the E2-induced increase in pi tuitary DA, but this dose of P (approximately 35 ng/ml plasma, roughly half of the levels seen in mid-pregnancy) [19] did not reduce pituitary DA to levels found in OVX mice: higher doses of P may be required. The age-related increase in pituitary DA in female mice is primarily due to ovarian factors, and eventually returns to young basal values after OVX [41], The attenuation of both the E^-induced and age-related increase of pituitary DA by P is consistent with a primary role of E: in this age change ( fig.…”
Section: Discussionmentioning
confidence: 75%
“…Unless otherwise stated in the figure legends, plasma E2 from these implants was 15-20 pg E2/ml plasma. The P-containing Silastic implants used in this study yield approximately 35 ng P/ml plasma [19]. When OVX mice were treated with both E2 and P, the E2 and P implants were given si multaneously 3 weeks before sacrifice.…”
Section: Animals and Treatmentmentioning
confidence: 99%
“…While aging female rodents do not undergo true menopause, they do become reproductively incompetent or senescent with advanced age, a state referred to as estropause. Estropause is characterized by persistently lower estrogen, varying length of the estrous cycle, with eventual cessation of cyclicity around 12-14 months of age [ 71 ] . Ovariectomy of aged animals supports the loss of estrogen with aging, as animals do not undergo changes in metabolic function with ovarian estrogen removal, nor do significant changes in cardiac phenotype occur with removal of the ovaries [ 72 ] .…”
Section: Mechanisms Of Sex Differences In Cardiac Agingmentioning
confidence: 99%